Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are tre...
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
To investigate the ameliorating effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on blood glucose control in patients with type 2 diabetes mellitus who were previously untreated with or who have a poor responsive to existing antidiabetic drugs.
Sitagliptin (50 mg/day) was added on to the pre-existing therapy for type 2 diabetes and cha...
Alternative Titles
Full title
Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_abc9e6be1d1948a0bd3612a4e055e032
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_abc9e6be1d1948a0bd3612a4e055e032
Other Identifiers
ISSN
1472-6823
E-ISSN
1472-6823
DOI
10.1186/s12902-016-0149-z
